[1] Wang F, Zheng Z.Two cases of hypersensitivity induced by rt-PA and literature analysis[J]. Prevention and Treatment of Cardio-Vascular Disease(心脑血管病防治), 2017, 17(1): 66-68. [2] Ning JK, Yang CY.One case of chill and fever induced by rt-PA[J]. Herald of Medicine(医药导报), 2014, 33(8): 1106-1107. [3] Li M, Sun DY.One case of tongue angiogenic edema induced by rt-PA in a patient with acute cerebral infarction[J]. Chinese Journal of Geriatric Heart Brain and Vessel Diseases(中华老年心脑血管病杂志), 2013, 15(4): 435. [4] Hu J, Yan Y, Rong W, et al.One case of hypotension induced by rt-PA in a patient with acute cerebral infarction[J]. Journal of International Neurology and Neurosurgery(国际神经病学神经外科学杂志), 2019, 46(5): 546-547. [5] Yang XL, Li F, Feng JL.One case of shock induced by rt-PA in a patient with acute cerebral infarction[J]. Journal of Clinical Neurology(临床神经病学杂志), 2018, 31(4): 263. [6] Yan Y, Huang C.One case of intracranial hemorrhage caused by rt-PA[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2010, 7(11): 697. [7] Yu H, Zhou YG.One case of acute ischemic stroke with hemorrhage after thrombolysis induced by rt-PA[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2016, 13(7): 443-444. [8] Qiu YL, Li CC, Hu SS, et al.One case of Intracranial hemorrhage caused by rt-PA[J]. China Pharmaceuticals(中国药业),2020, 29(3): 93-94. [9] Wu N, Wang QR, Shang TQ.One case of intracranial hemorrhage caused by rt-PA[J]. Chinese Journal of Clinical Rational Drug Use(临床合理用药), 2019, 12(9A): 73. [10] Alakbarzade V, O'Kane D, Pereira AC. Hypersensitivity reactions to recombinant tissue plasminogen activator[J]. Practical Neurology, 2020, 20(1): 75-79. [11] Burd M, McPheeters C, Scherrer LA. Orolingual angioedema after tissue plasminogen activator administration in patients taking angiotensin-converting enzyme inhibitors[J]. Adv Emerg Nurs J, 2019, 41(3): 204-214. [12] Wang CT, Lin FC, Khor GT, et al. Life-threatening anaphylactoid shock caused by recombinant tissue plasminogen activator[J]. The American Journal of Emergency Medicine, 2012, 30(1): 253. e1-e2. [13] Foster-Goldman A, McCarthy D. Angioedema from recombinant TPA administration: case report and pathophysiology review[J]. Am J Ther, 2013, 20(6): 691-693. [14] Censori B, Partziguian T, Bonito V, et al.Incidence of orolingual angioedema after intravenous thrombolysis for stroke[J]. Neurol Sci, 2018, 39(11): 1877-1879. [15] Cheong E, Dodd L, Smith W, et al.Icatibant as a potential treatment of life-threatening alteplase-induced angioedema[J]. J Stroke Cerebrovasc Dis, 2018, 27(2): e36-e37. [16] Wang YX, Li YQ, Chen Y, et al.Analysis of related factors of orolin-gual angioedema after rt-PA intravenous thrombolytic therapy[J].Eur Rev Med Pharmacol Sci, 2018, 22(5): 1478-1484. [17] Campo P, Fernandez TD, Canto G, et al.Angioedema induced by an-giotensin-converting enzyme inhibitors[J].Curr Opin Allergy ClinImmuno, 2013, 13(4): 337-344. [18] Mehrpour M, Motamed MR, Aghaei M, et al.Retrosternal mass: an interesting allergic reaction to intravenous thrombolytic therapy for acuteischemic stroke[J].Iran J Neurol, 2013, 12(3): 114-116. [19] Hill MD, Barber PA, Takahashi J, et al.Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke[J].CMAJ, 2000, 162(9): 1281-1284. [20] Fugate JE, Kalimullah EA, Wijdicks EF.Angioedema after tPA: what neurointensivists should know[J].Neurocrit Care, 2012, 16(3): 440-443. |